-+ 0.00%
-+ 0.00%
-+ 0.00%

Maravai LifeSciences Raises FY2026 Sales Guidance from $205.000M-$215.000M to $212.000M-$216.000M vs $211.767M Est

Benzinga·11/04/2026 21:34:32
Maravai LifeSciences (NASDAQ:MRVI) raises FY2026 sales outlook from $205.000 million-$215.000 million to $212.000 million-$216.000 million vs $211.767 million estimate.